By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antigout agents > Probenecid > Probenecid Dosage
Antigout agents
https://themeditary.com/dosage-information/probenecid-dosage-6464.html

Probenecid Dosage

Drug Detail:Probenecid (Probenecid [ proe-ben-a-sid ])

Drug Class: Antigout agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Gout

Therapy should not be started until an acute gout attack has subsided:

Initial: 250 mg orally twice a day for 1 week
Maintenance: 500 mg orally twice a day

  • If symptoms of gouty arthritis are not controlled or 24-hour uric acid excretion is not above 700 mg, may increase dose in 500 mg increments every 4 weeks as tolerated; continue at dose that maintains normal serum urate levels
Maximum dose: 2 g per day

Comments:
  • If an acute attack is precipitated during therapy, this drug should be continued at same dose while appropriate therapy is given to control acute attack.
  • To prevent crystallization of uric acid in urine, a liberal fluid intake (2 L/day) and alkalization of the urine should be encouraged; alkalization of urine may be relaxed when serum urate levels return to normal limits and tophaceous deposits disappear.
  • Maintenance dose may be decreased in increments of 500 mg every 6 months when acute attacks have been absent for 6 months or more and serum urate levels remain within normal limits; maintenance dosage should not be reduced to the point serum urate levels start to rise.

Use: For the treatment of hyperuricemia associated with gout and gouty arthritis.

Usual Adult Dose for Gouty Arthritis

Therapy should not be started until an acute gout attack has subsided:

Initial: 250 mg orally twice a day for 1 week
Maintenance: 500 mg orally twice a day

  • If symptoms of gouty arthritis are not controlled or 24-hour uric acid excretion is not above 700 mg, may increase dose in 500 mg increments every 4 weeks as tolerated; continue at dose that maintains normal serum urate levels
Maximum dose: 2 g per day

Comments:
  • If an acute attack is precipitated during therapy, this drug should be continued at same dose while appropriate therapy is given to control acute attack.
  • To prevent crystallization of uric acid in urine, a liberal fluid intake (2 L/day) and alkalization of the urine should be encouraged; alkalization of urine may be relaxed when serum urate levels return to normal limits and tophaceous deposits disappear.
  • Maintenance dose may be decreased in increments of 500 mg every 6 months when acute attacks have been absent for 6 months or more and serum urate levels remain within normal limits; maintenance dosage should not be reduced to the point serum urate levels start to rise.

Use: For the treatment of hyperuricemia associated with gout and gouty arthritis.

Usual Adult Dose for Adjunct to Antibiotic Therapy

500 mg orally 4 times a day

Comment: The Centers for Disease Control and Prevention (CDC) no longer recommend this drug with oral cephalosporins or ampicillin as a treatment for gonococcal infections.

Use: As an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given.

Usual Pediatric Dose for Adjunct to Antibiotic Therapy

Age: 2 to 14 years and weight less than 50 kg:
Initial: 25 mg/kg (or 0.7 g/m2 ) orally once
Maintenance: 40 mg/kg (or 1.2 g/m2/) per day orally administered in 4 equally divided doses 4 times a day

Weight greater than 50 kg:
500 mg orally 4 times a day

Comment: The Centers for Disease Control and Prevention (CDC) no longer recommend this drug with oral cephalosporins or ampicillin as a treatment for gonococcal infections.

Use: As an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is give.

Renal Dose Adjustments

Gout:

  • Chronic renal insufficiency (CrCl less than 30 mL/min): Not recommended as it may not be effective
  • Renal impairment: Use caution; dosage requirements may be increased in some patients with some renal impairment

Adjunct to penicillin:
  • Not recommended in conjunction with penicillin in the presence of known renal impairment.
  • If used in elderly patients with renal impairment, use caution, dose reduction may be warranted, specific guidelines are not provided

Liver Dose Adjustments

Data not available

Dose Adjustments

Urine alkalization:

  • A liberal fluid intake (2 L/day) and alkalization of the urine is recommended when excretion of uric acid is at a high level; alkalization may be relaxed when serum urate levels return to normal and tophaceous deposits disappear.
  • Sodium bicarbonate 3 to 7.5 g/day or potassium citrate 7.5 g/day may be used to maintain an alkaline urine.
  • Acid-base balance should be watched carefully when alkali is administered.

Adjunct to antibiotic:
Phenolsulfonphthalein (PSP) excretion test may be used to determine the effectiveness of probenecid in retarding penicillin excretion and maintaining therapeutic levels; the renal clearance of PSP is reduced to about one-fifth the normal rate when dosage of probenecid is adequate.

Precautions

Contraindicated in children less than 2 years of age

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
Take orally

Gout:

  • Maintain adequate hydration (at least 2 L/day) and alkalization of the urine with sodium bicarbonate or potassium citrate as needed.

Storage requirements:
  • Protect from light

General:
  • Gastric intolerance may be indicative of toxicity and can be corrected by decreasing dosage.
  • This drug should not be started until an acute gouty attack has subsided; if an acute attack is precipitated during therapy, this drug should be continued at same dose while appropriate therapy is given to control acute attack.
  • This drug inhibits the tubular secretion of penicillin and usually increases penicillin plasma levels 2 to 4 fold.

Monitoring:
Gout:
  • Monitor serum urate levels as needed to determine adequacy of treatment
  • Monitor acid-base balance in patients administered alkali.

Patient advice:
  • Instruct patients on the need for adequate hydration, alkalization of the urine, and/or dietary restrictions appropriate to their care.
  • Inform patients that salicylates may diminish the uricosuric effect of this drug; if a mild analgesic agent is needed, acetaminophen should be used.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by